3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colonic Neoplasms
3
Peritoneal Neoplasms
2
Colorectal Neoplasms
2
Rectal Neoplasms
1
Ovarian Neoplasms
1
Neoplastic Cells, Circulating
1
Melanoma
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Liver Neoplasms
1
Genital Neoplasms, Female
1
Gastrointestinal Stromal Tumors
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Interventions
Nivolumab
37
pembrolizumab
26
cabozantinib
26
Specimen Handling
23
Magnetic Resonance Spectroscopy
21
Ipilimumab
19
lenvatinib
13
belzutifan
13
Axitinib
13
CTLA-4 Antigen
10
Sunitinib
9
Radiosurgery
8
Biopsy
8
atezolizumab
7
fludarabine
4
avelumab
4
aldesleukin
4
Immunoglobulin G
4
Disulfides
4
zimberelimab
3
toripalimab
3
tivozanib
3
pazopanib
3
palbociclib
3
durvalumab
3
cemiplimab
3
Surveys and Questionnaires
3
Nephrectomy
3
Everolimus
3
Cyclophosphamide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Laparoscopy
×
90 days
×
Clear all
No trials found.